FDA Inspection 1224221 — Konstantinos Avraam, MD
The FDA completed an inspection of Konstantinos Avraam, MD on Oct 20, 2023 in Antwerp. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 20, 2023
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Antwerp (Belgium)
Additional Details
Clinical Investigator (CI)